Literature DB >> 17341866

The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.

Yin-Ku Lin1, Wen-Rou Wong, Ya-Ching Chang, Chee-Jen Chang, Pei-Kwei Tsay, Shu-Chen Chang, Jong-Hwei Su Pang.   

Abstract

BACKGROUND: It has been reported in the Chinese literature that indigo naturalis exhibits potential antipsoriatic effects in systemic therapy.
OBJECTIVE: To evaluate the efficacy and safety of topically applied indigo naturalis on treating plaque-type psoriasis and to analyze the histological change in skin tissues.
METHODS: Fourteen patients with chronic plaque psoriasis were enrolled. The patients were topically applied with either indigo naturalis ointment or vehicle ointment on contralateral skin lesions daily for 8 weeks. Efficacy was evaluated on the basis of the clinical scores, including induration, scaling, erythema and clearing percentage. At the end of treatment, skin punch biopsies were taken and prepared for the immunohistochemical analysis.
RESULTS: A significant reduction in clinical scores was achieved with topically applied indigo naturalis ointment. Analysis of biopsies showed a marked improvement of skin histology. The expressions of proliferating marker Ki-67 and inflammatory marker CD3 were decreased, but the differentiation marker such as filaggrin was increased in the epidermis after indigo naturalis ointment treatment.
CONCLUSIONS: The results suggest that topical application of indigo naturalis ointment may be a novel, safe and effective therapy for psoriasis that is mediated, at least in part, by modulating the proliferation and differentiation of keratinocytes in epidermis, as well as by inhibiting the infiltration of T lymphocytes and therefore the subsequent inflammatory reactions in psoriatic lesions. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17341866     DOI: 10.1159/000098576

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  12 in total

1.  Exploratory clinical trial to evaluate the efficacy of a topical traditional chinese herbal medicine in psoriasis vulgaris.

Authors:  Yuhe Yan; Wali Liu; Philippe Andres; Colette Pernin; Laurent Chantalat; Philippe Briantais; Albert Lin; Lilian Feng
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-05       Impact factor: 2.629

2.  The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.

Authors:  Hsin-Ju Li; Nan-Lin Wu; Gon-Ann Lee; Chi-Feng Hung
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

3.  Inhibitory effect of indigo naturalis on tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells.

Authors:  Hsin-Ning Chang; Jong-Hwei Su Pang; Sien-Hung Yang; Chi-Feng Hung; Chi-Hsin Chiang; Tung-Yi Lin; Yin-Ku Lin
Journal:  Molecules       Date:  2010-09-14       Impact factor: 4.411

Review 4.  Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis.

Authors:  Tse-Hung Huang; Chwan-Fwu Lin; Ahmed Alalaiwe; Shih-Chun Yang; Jia-You Fang
Journal:  Int J Mol Sci       Date:  2019-05-24       Impact factor: 6.208

Review 5.  Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation.

Authors:  Nieves Fernández-Gallego; Francisco Sánchez-Madrid; Danay Cibrian
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

6.  Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.

Authors:  Ze-Huai Wen; Mei-Ling Xuan; Yu-Hong Yan; Xiao-Yan Li; Dan-Ni Yao; Geng Li; Xin-Feng Guo; Ai-Hua Ou; Chuan-Jian Lu
Journal:  Trials       Date:  2014-07-22       Impact factor: 2.279

7.  A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.

Authors:  Liming Lu; Meiling Xuan; Yuhong Yan; Geng Li; Li Zhou; Zehuai Wen; Chuanjian Lu
Journal:  Trials       Date:  2016-10-03       Impact factor: 2.279

8.  Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study.

Authors:  L Cai; J Gu; J Zheng; M Zheng; G Wang; L-Y Xi; F Hao; X-M Liu; Q-N Sun; Y Wang; W Lai; H Fang; Y-T Tu; Q Sun; J Chen; X-H Gao; Y Gu; H D Teixeira; J-Z Zhang; M M Okun
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-08-09       Impact factor: 6.166

9.  Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis.

Authors:  Hui-Man Cheng; Yang-Chang Wu; Qingmin Wang; Michael Song; Jackson Wu; Dion Chen; Katherine Li; Eric Wadman; Shung-Te Kao; Tsai-Chung Li; Francisco Leon; Karen Hayden; Carrie Brodmerkel; C Chris Huang
Journal:  BMC Complement Altern Med       Date:  2017-09-02       Impact factor: 3.659

Review 10.  Integrative Dermatology - The Use of Herbals and Nutritional Supplements to Treat Dermatological Conditions.

Authors:  Michael Tirant; Torello Lotti; Serena Gianfaldoni; Georgi Tchernev; Uwe Wollina; Philip Bayer
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.